Form D · Pharmaceuticals

FLUOROPHARMA MEDICAL, INC.

Montclair, NJ · CIK 0001402785

Offering snapshot reported Apr 6, 2016 · SEC filing

Reported sold
$150K
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 23, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 6, 2016Initial$150,000No comparison1SEC filing
Jun 8, 2015Initial$350,000No comparison3SEC filing
Jul 28, 2014Initial$1,222,500No comparison23SEC filing
Jan 10, 2014Initial$877,500No comparison16SEC filing
Sep 27, 2013Initial$737,500No comparison11SEC filing
Jul 8, 2013Initial$250,000No comparison2SEC filing
Nov 21, 2012Initial$1,546,250No comparison14SEC filing
Jul 7, 2011Initial$2,355,621No comparison31SEC filing
Jun 1, 2011Initial$3,667,442No comparison31SEC filing
Jun 6, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-260742

Source: Form D, filed Apr 6, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lawrence H. Atinsky Director
Peter S. Conti Director
David R. Elmaleh Director, Executive
W. Austin H. Lewis Director
Joseph A. Pierro Director
Tamara H. Rhein Executive
Andrew H. Sassine Director
Johan (Thijs) M. Spoor Director
Johan (Thjis) Spoor Director, Executive
Johan (Thijs) M. Spoor Director, Executive
Thomas H. Tulip Director, Executive
Walter H. Witoshkin Director
Walter Witshkin Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
8 Hillside Avenue Suite 108
Montclair, NJ, 07042